References

Benjamin, I. J., C. M. Valentine, W. J. Oetgen, K. A. Sheehan, R. G. Brindis, W. H. Roach, R. A. Harrington, G. N. Levine, R. F. Redberg, B. M. Broccolo, A. F. Hernandez, P. S. Douglas, I. L. Piña, E. J. Benjamin, M. J. Coylewright, J. F. Saucedo, K. C. Ferdinand, S. N. Hayes, A. Poppas, K. L. Furie, L. S. Mehta, J. P. Erwin, J. H. Mieres, D. J. Murphy, G. Weissman, C. P. West, W. E. Lawrence, F. A. Masoudi, C. P. Jones, D. D. Matlock, J. E. Miller, J. A. Spertus, L. Todman, C. Biga, R. A. Chazal, M. A. Creager, E. T. Fry, M. J. Mack, C. W. Yancy, and R. E. Anderson. 2021. 2020 American Heart Association and American College of Cardiology consensus conference on professionalism and ethics: A consensus conference report. Journal of the American College of Cardiology 77(24):3079–3133. https://doi.org/doi:10.1016/j.jacc.2021.04.004.

Bero, L. 2019. Ten tips for spotting industry involvement in science policy. Tobacco Control 28(1):1–2. https://doi.org/10.1136/tobaccocontrol-2018-054386.

Bero, L. A., and Q. Grundy. 2016. Why having a (nonfinancial) interest is not a conflict of interest. PLoS Biology 14(12):e2001221. https://doi.org/10.1371/journal.pbio.2001221.

Brandt, A. M. 2012. Inventing conflicts of interest: A history of tobacco industry tactics. American Journal of Public Health 102(1):63–71. https://doi.org/10.2105/ajph.2011.300292.

Brauer, M., J. R. Brook, T. Christidis, Y. Chu, D. Crouse, and A. Erickson. 2022. Mortality–air pollution associations in low-exposure environments (MAPLE): Phase 2. Boston, MA: Health Effects Institute.

Brouwers, M. C., M. E. Kho, G. P. Browman, J. S. Burgers, F. Cluzeau, G. Feder, B. Fervers, I. D. Graham, J. Grimshaw, S. E. Hanna, P. Littlejohns, J. Makarski, and L. Zitzelsberger. 2010. AGREE II: Advancing guideline development, reporting and evaluation in health care. Canadian Medical Association Journal 182(18):E839–842. https://doi.org/10.1503/cmaj.090449.

Brunekreef, B., M. Strak, J. Chen, Z. J. Andersen, R. Atkinson, and M. Bauwelinck. 2021. Mortality and morbidity effects of long-term exposure to low-level PM 2.5, BC, NO₂, and O₃: An analysis of European cohorts in the ELAPSE project. Boston, MA: Health Effects Institute.

Chang, E. T., E. C. Lau, C. Van Landingham, K. S. Crump, R. O. McClellan, and S. H. Moolgavkar. 2018. Reanalysis of diesel engine exhaust and lung cancer mortality in the Diesel Exhaust in Miners Study cohort using alternative exposure estimates and radon adjustment. American Journal of Epidemiology 187(6):1210–1219. https://doi.org/10.1093/aje/kwy038.

Chartres, N., A. Fabbri, and L. A. Bero. 2016. Association of industry sponsorship with outcomes of nutrition studies: A systematic review and meta-analysis. JAMA Internal Medicine 176(12):1769–1777.

Chartres, N., A. Fabbri, S. McDonald, J. Diong, J. E. McKenzie, and L. Bero. 2020. Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: Systematic review and meta-analysis. BMJ Open 10(12):e039036. https://doi.org/10.1136/bmjopen-2020-039036.

Cheney, G., D. Lair, D. Ritz, and B. Kendall. 2010. Just a job?: Communication, ethics, and professional life. Oxford University Press.

Chimonas, S., M. Mamoor, S. A. Zimbalist, B. Barrow, P. B. Bach, and D. Korenstein. 2021. Mapping conflict of interests: Scoping review. BMJ 375:e066576. https://doi.org/10.1136/bmj-2021-066576.

Ciresi, M. V., R. B. Walburn, and T. D. Sutton. 1999. Decades of deceit: Document discovery in the Minnesota tobacco litigation. William Mitchell Law Review 25(2):84.

Cogliano, V., R. Baan, K. Straif, Y. Grosse, B. Secretan, F. El Ghissassi, and P. Boyle. 2005. Transparency in IARC monographs. The Lancet Oncology 6(10):747.

Collingridge, D. 2005. Increased transparency in IARC monograph programme. The Lancet Oncology 6(10):735.

Crump, K. S., C. Van Landingham, S. H. Moolgavkar, and R. McClellan. 2015. Reanalysis of the DEMS nested case-control study of lung cancer and diesel exhaust: Suitability for quantitative risk assessment. Risk Analysis 35(4):676–700. https://doi.org/10.1111/risa.12371.

Crump, K. S., C. Van Landingham, and R. O. McClellan. 2016. Influence of alternative exposure estimates in the Diesel Exhaust Miners study: Diesel exhaust and lung cancer. Risk Analysis 36(9):1803–1812. https://doi.org/10.1111/risa.12556.

Diethelm, P. A., J. C. Rielle, and M. McKee. 2005. The whole truth and nothing but the truth? The research that Philip Morris did not want you to see. Lancet 366(9479):86–92. https://doi.org/10.1016/s0140-6736(05)66474-4.

Dominici, F., A. Zanobetti, J. Schwartz, D. Braun, B. Sabath, and X. Wu. 2022. Assessing adverse health effects of long-term exposure to low levels of ambient air pollution: Implementation of causal inference methods. Boston, MA: Health Effects Institute.

Dunn, A. G. 2016. Set up a public registry of competing interests. Nature 533(7601):9–9. https://doi.org/10.1038/533009a.

Effective Health Care Program, AHRQ (Agency for Healthcare Research and Quality). 2021. Evidence-based practice centers. https://effectivehealthcare.ahrq.gov/about/epc (accessed March 17, 2023).

Effective Health Care Program, AHRQ. 2022. Systematic review: Management of infantile epilepsies. https://effectivehealthcare.ahrq.gov/products/management-infantileepilepsy/research (accessed February 3, 2023).

Elder, K., K. A. Turner, L. Cosgrove, J. Lexchin, A. Shnier, A. Moore, S. Straus, and B. D. Thombs. 2020. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: A descriptive study. Canadian Medical Association Journal 192(23):e617–e625. https://doi.org/10.1503/cmaj.191737.

Erickson, J., B. Sadeghirad, L. Lytvyn, J. Slavin, and B. C. Johnston. 2017. The scientific basis of guideline recommendations on sugar intake: A systematic review. Annals of Internal Medicine 166(4):257–267. https://doi.org/10.7326/m16-2020.

Fabbri, A., T. J. Holland, and L. A. Bero. 2018. Food industry sponsorship of academic research: Investigating commercial bias in the research agenda. Public Health Nutrition 21(18):3422–3430. https://doi.org/10.1017/s1368980018002100.

Fazzino, T. L., J. L. Dorling, J. W. Apolzan, and C. K. Martin. 2021. Meal composition during an ad libitum buffet meal and longitudinal predictions of weight and percent body fat change: The role of hyper-palatable, energy dense, and ultra-processed foods. Appetite 167:105592. https://doi.org/10.1016/j.appet.2021.105592.

Frampton, M. W., J. R. Balmes, P. A. Bromberg, P. Stark, M. Arjomandi, M. J. Hazucha, D. Q. Rich, D. Hollenbeck-Pringle, N. Dagincourt, N. E. Alexis, P. Ganz, W. Zareba, and M. G. Costantini. 2017. Multicenter Ozone Study in Older Subjects (MOSES): Part 1. Effects of exposure to low concentrations of ozone on respiratory and cardiovascular outcomes. Boston, MA: Health Effects Institute.

Gaffney, A., Lexchin, J., U.S., Canadian Pharmaceutical Policy Reform Working Group. 2018. Healing an ailing pharmaceutical system: Prescription for reform for United States and Canada. BMJ 361:k1039.

Grundy, Q., A. G. Dunn, F. T. Bourgeois, E. Coiera, and L. Bero. 2018. Prevalence of disclosed conflicts of interest in biomedical research and associations with journal impact factors and altmetric scores. JAMA 319(4):408–409. https://doi.org/10.1001/jama.2017.20738.

Hall, K. D., A. Ayuketah, R. Brychta, H. Cai, T. Cassimatis, K. Y. Chen, S. T. Chung, E. Costa, A. Courville, V. Darcey, L. A. Fletcher, C. G. Forde, A. M. Gharib, J. Guo, R. Howard, P. V. Joseph, S. McGehee, R. Ouwerkerk, K. Raisinger, I. Rozga, M. Stagliano, M. Walter, P. J. Walter, S. Yang, and M. Zhou. 2019. Ultra-processed diets cause excess calorie intake and weight gain: An inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism 30(1):67–77. https://doi.org/10.1016/j.cmet.2019.05.008.

Hall, R. H. 1968. Professionalization and bureaucratization. American Sociological Review 33(1):92–104. https://doi.org/10.2307/2092242.

Harris, R. F. 2017. Rigor mortis: How sloppy science creates worthless cures, crushes hope, and wastes billions. New York: Basic Books.

Harrison, E., P. Martin, D. Surian, and A. G. Dunn. 2020. Recommending research articles to consumers of online vaccination information. Quantitative Science Studies 1(2):810–823. https://doi.org/10.1162/qss_a_00030.

HEI (Health Effects Institute). 1991. Asbestos in public and commercial buildings: A literature review and synthesis of current knowledge. Boston, MA: Health Effects Institute.

Hobæk, B. and Lie, A. K. 2019. Less is more: Norwegian drug regulation, antibiotic policy, and the “need clause.” The Milbank Quarterly 97(3):762–795.

IOM (Institute of Medicine). 2009. Conflict of interest in medical research, education, and practice. Edited by B. Lo and M. J. Field. Washington, DC: The National Academies Press.

IOM. 2011. Clinical practice guidelines we can trust. Edited by R. Graham, M. Mancher, D. M. Wolman, S. Greenfield, and E. Steinberg. Washington, DC: The National Academies Press.

IOM. 2014. Conflict of interest and medical innovation: Ensuring integrity while facilitating innovation in medical research: Workshop summary. Edited by S. H. Beachy, A. C. Berger, and S. Olson. Washington, DC: The National Academies Press.

Italian Medicines Agency (AIFA) Research & Development Working Group, 2010. Feasibility and challenges of independent research on drugs: The Italian Medicines Agency (AIFA) experience. European Journal of Clinical Investigation 40(1):69–86.

Jack, M. M. 2017. Do sugar-sweetened beverages cause obesity and diabetes? Annals of Internal Medicine 167(1):72. https://doi.org/10.7326/l17-0192.

Kazatchkine, M., J. Kinderlerer, and A. Gilligan. 2017. Twenty-point plan for science policy. Nature 541(7637):289–289. https://doi.org/10.1038/541289a.

Kennedy, B., A. Tyson, and C. Funk. 2022. Americans’ trust in scientists, other groups declines. Washington, DC: Pew Research Center.

Kesselheim, A. S., C. T. Robertson, J. A. Myers, S. L. Rose, V. Gillet, K. M. Ross, R. J. Glynn, S. Joffe, and J. Avorn. 2012. A randomized study of how physicians interpret research funding disclosures. New England Journal of Medicine 367(12):1119–1127. https://doi.org/10.1056/NEJMsa1202397.

The Lancet. 2003. Transparency at IARC. The Lancet 361(9353):189. https://doi.org/10.1016/S0140-6736(03)12257-X.

Lexchin, J. 2009. CJEM and pharmaceutical advertisements: It’s time for an end. Canadian Journal of Emergency Medicine 11(4). Cambridge University Press. Pp. 375–79. https://doi.org/10.1017/S1481803500011441.

Lexchin, J., L. A. Bero, C. Davis, and M.-A. Gagnon. 2021. Achieving greater independence from commercial influence in research. BMJ 372:n370. https://doi.org/10.1136/bmj.n370.

Litman, E. A., S. L. Gortmaker, C. B. Ebbeling, and D. S. Ludwig. 2018. Source of bias in sugar-sweetened beverage research: A systematic review. Public Health Nutrition 21(12):2345–2350. https://doi.org/10.1017/s1368980018000575.

Liu, S., F. T. Bourgeois, and A. G. Dunn. 2022. Identifying unreported links between clinicaltrials.gov trial registrations and their published results. Research Synthesis Methods 13(3):342–352. https://doi.org/10.1002/jrsm.1545.

Lundh, A., J. Lexchin, B. Mintzes, J. B. Schroll, and L. Bero. 2017. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews (2). https://doi.org/10.1002/14651858.MR000033.pub3.

Martínez Steele, E., L. G. Baraldi, M. L. d. C. Louzada, J.-C. Moubarac, D. Mozaffarian, and C. A. Monteiro. 2016. Ultra-processed foods and added sugars in the U.S. diet: Evidence from a nationally representative cross-sectional study. BMJ Open 6(3):e009892. https://doi.org/10.1136/bmjopen-2015-009892.

McCormick, B. B., G. Tomlinson, P. Brill-Edwards, and A. S. Detsky. 2001. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 286(16):1994–1999. https://doi.org/10.1001/jama.286.16.1994.

McCormick, B. B., G. Tomlinson, P. Brill-Edwards, and A. S. Detsky. 2002. Long-term effects of restricting residents’ contacts with drug representatives. AAP Grand Rounds 7(3):32–32. https://doi.org/10.1542/gr.7-3-32.

Michaels, D. 2020. The triumph of doubt: Dark money and the science of deception. Oxford: Oxford University Press.

Mitra-Majumdar, M., and A. S. Kesselheim. 2022. Reporting bias in clinical trials: Progress toward transparency and next steps. PLoS Medicine 19(1):e1003894. https://doi.org/10.1371/journal.pmed.1003894.

Monteiro, C. A., G. Cannon, J. C. Moubarac, R. B. Levy, M. L. C. Louzada, and P. C. Jaime. 2018. The UN decade of nutrition, the NOVA food classification and the trouble with ultra-processing. Public Health Nutrition 21(1):5–17. https://doi.org/10.1017/s1368980017000234.

Moynihan, R., H. Macdonald, C. Heneghan, L. Bero, and F. Godlee. 2019. Commercial interests, transparency, and independence: A call for submissions. BMJ 365:l1706. https://doi.org/10.1136/bmj.l1706.

Moynihan, R., L. Albarqouni, C. Nangla, A. G. Dunn, J. Lexchin, and L. Bero. 2020. Financial ties between leaders of influential U.S. professional medical associations and industry: Cross sectional study. BMJ 369:m1505. https://doi.org/10.1136/bmj.m1505.

Mozaffarian, D., and N. G. Forouhi. 2018. Dietary guidelines and health—is nutrition science up to the task? BMJ 360:k822. https://doi.org/10.1136/bmj.k822.

Nanda, A. 2003. The essence of professionalism: Managing conflicts of interest. Harvard Business School Background Note 903–120 June:3.

Nestle, M. 2002. Food politics: How the food industry influences nutrition and health. Berkeley, CA: University of California Press.

Nguyen, K. H., S. A. Glantz, C. N. Palmer, and L. A. Schmidt. 2019. Tobacco industry involvement in children’s sugary drinks market. BMJ 364:l736. https://doi.org/10.1136/bmj.l736..

Nguyen, K. H., S. A. Glantz, C. N. Palmer, and L. A. Schmidt. 2020. Transferring racial/ ethnic marketing strategies from tobacco to food corporations: Philip Morris and Kraft general foods. American Journal of Public Health 110(3):329–336.

O’Connor, A. 2015. Coca-Cola funds scientists who shift blame for obesity away from bad diets. https://archive.nytimes.com/well.blogs.nytimes.com/2015/08/09/coca-cola-funds-scientists-who-shift-blame-for-obesity-away-from-bad-diets/ (accessed April 20, 2023).

Odierna, D. H., S. R. Forsyth, J. White, and L. A. Bero. 2013. The cycle of bias in health research: A framework and toolbox for critical appraisal training. Accountability in Research 20(2):127–141. https://doi.org/10.1080/08989621.2013.768931.

Oxfam International, Behind the Brands: Food Justice and the ‘Big 10’ Food and Beverage Companies, Oxfam Briefing Paper 166, Feb 26, 2013. http://www.behindthebrands.org (accessed May 8, 2023).

Parker, L., and L. Bero. 2022. Managing risk from conflicts of interest in guideline development committees. BMJ 379:e072252. https://doi.org/10.1136/bmj-2022-072252.

Paustenbach, D. J., J. M. Panko, P. K. Scott, and K. M. Unice. 2006. A methodology for estimating human exposure to perfluorooctanoic acid (PFOA): A retrospective exposure assessment of a community (1951–2003). Journal of Toxicology and Environmental Health, Part A 70(1):28–57. https://doi.org/10.1080/15287390600748815.

Prinz, F., T. Schlange, and K. Asadullah. 2011. Believe it or not: How much can we rely on published data on potential drug targets? Nature Reviews Drug Discovery 10(9):712–712. https://doi.org/10.1038/nrd3439-c1.

Rasmussen, K., L. Bero, R. Redberg, P. C. Gøtzsche, and A. Lundh. 2018. Collaboration between academics and industry in clinical trials: Cross sectional study of publications and survey of lead academic authors. BMJ 363:k3654. https://doi.org/10.1136/bmj.k3654.

Rich, D. Q., M. W. Frampton, J. R. Balmes, P. A. Bromberg, M. Arjomandi, M. J. Hazucha, S. W. Thurston, N. E. Alexis, P. Ganz, W. Zareba, P. Koutrakis, and K. Thevenet-Morrison. 2020. Multicenter Ozone Study in Older Subjects (MOSES): Part 2. Effects of personal and ambient concentrations of ozone and other pollutants on cardiovascular and pulmonary function. Boston, MA: Health Effects Institute.

Rose, S. L., S. Sah, R. Dweik, C. Schmidt, M. Mercer, A. Mitchum, M. Kattan, M. Karafa, and C. Robertson. 2021. Patient responses to physician disclosures of industry conflicts of interest: A randomized field experiment. Organizational Behavior and Human Decision Processes 166:27–38.

Rubenfeld, G. D. 2007. The conflict vitae: A CV for the new millennium. Lancet 370(9584):318. https://doi.org/10.1016/s0140-6736(07)61159-3.

Sah, S. 2017. Policy solutions to conflicts of interest: The value of professional norms. Behavioural Public Policy 1(2):177–189. https://doi.org/10.1017/bpp.2016.9.

Sah, S. 2019a. Conflict of interest disclosure as a reminder of professional norms: Clients first! Organizational Behavior and Human Decision Processes 154:62–79. https://doi.org/10.1016/j.obhdp.2019.07.005.

Sah, S. 2019b. Understanding the (perverse) effects of disclosing conflicts of interest: A direct replication study. Journal of Economic Psychology 75:102118. https://doi.org/10.1016/j.joep.2018.10.010.

Sah, S. 2022. The professionalism paradox: A sense of professionalism increases vulnerability to conflicts of interest. Academy of Management Perspectives 36(3):896–918. https://doi.org/10.5465/amp.2021.0033.

Sah, S., and D. Feiler. 2020. Conflict of interest disclosure with high-quality advice: The disclosure penalty and the altruistic signal. Psychology, Public Policy, and Law 26:88–104. https://doi.org/10.1037/law0000215.

Sah, S., and G. Loewenstein. 2014. Nothing to declare: Mandatory and voluntary disclosure leads advisors to avoid conflicts of interest. Psychological Science 25:575–584. https://doi.org/10.1177/0956797613511824.

Sah, S., A. Fagerlin, and P. Ubel. 2016. Effect of physician disclosure of specialty bias on patient trust and treatment choice. Proceedings of the National Academy of Sciences of the United States of America 113(27):7465–7469. https://doi.org/10.1073/pnas.1604908113.

Schillinger, D., and M. F. Jacobson. 2016. Science and public health on trial: Warning notices on advertisements for sugary drinks. JAMA 316(15):1545–1546. https://doi.org/10.1001/jama.2016.10516.

Schillinger, D., and C. Kearns. 2017. Guidelines to limit added sugar intake: Junk science or junk food? Annals of Internal Medicine 166(4):305–306. https://doi.org/10.7326/m16-2754.

Schillinger, D., J. Tran, C. Mangurian, and C. Kearns. 2016. Do sugar-sweetened beverages cause obesity and diabetes? Industry and the manufacture of scientific controversy. Annals of Internal Medicine 165(12):895–897. https://doi.org/10.7326/l16-0534.

Schwartz, L. M., and S. Woloshin. 2019. Medical marketing in the United States, 1997–2016. JAMA 321(1):80–96. https://doi.org/10.1001/jama.2018.19320.

Scrinis, G. 2013. Nutritionism: The science and politics of dietary advice. New York: Columbia University Press.

Serôdio, P. M., M. McKee, and D. Stuckler. 2018. Coca-Cola—a model of transparency in research partnerships? A network analysis of Coca-Cola’s research funding (2008–2016). Public Health Nutrition 21(9):1594–1607. https://doi.org/10.1017/s136898001700307x.

Shah, Z., D. Surian, A. Dyda, E. Coiera, K. D. Mandl, and A. G. Dunn. 2019. Automatically appraising the credibility of vaccine-related web pages shared on social media: A Twitter surveillance study. Journal of Medical Internet Research 21(11):e14007. https://doi.org/10.2196/14007.

Silverman, D. T., C. M. Samanic, J. H. Lubin, A. E. Blair, P. A. Stewart, R. Vermeulen, J. B. Coble, N. Rothman, P. L. Schleiff, W. D. Travis, R. G. Ziegler, S. Wacholder, and M. D. Attfield. 2012. The Diesel Exhaust in Miners study: A nested case-control study of lung cancer and diesel exhaust. Journal of the National Cancer Institute 104(11):855–868. https://doi.org/10.1093/jnci/djs034.

Steinman, M. A., L. A. Bero, M. M. Chren, and C. S. Landefeld. 2006. Narrative review: The promotion of gabapentin: An analysis of internal industry documents. Annals of Internal Medicine 145(4):284–293. https://doi.org/10.7326/0003-4819-145-4-200608150-00008.

Stone, G. W., J. Lindenfeld, W. T. Abraham, S. Kar, D. S. Lim, J. M. Mishell, B. Whisenant, P. A. Grayburn, M. Rinaldi, S. R. Kapadia, V. Rajagopal, I. J. Sarembock, A. Brieke, S. O. Marx, D. J. Cohen, N. J. Weissman, and M. J. Mack. 2018. Transcatheter mitral-valve repair in patients with heart failure. New England Journal of Medicine 379(24):2307–2318. https://doi.org/10.1056/NEJMoa1806640.

Surian, D., F. T. Bourgeois, and A. G. Dunn. 2021. The automation of relevant trial registration screening for systematic review updates: An evaluation study on a large dataset of clinicaltrials.gov registrations. BMC Medical Research Methodology 21(1):281. https://doi.org/10.1186/s12874-021-01485-6.

Swan, N., S. Spindler, and Y. Pittman. 2019. Overview of guidelines for rigor in your application. https://grants.nih.gov/policy/reproducibility/guidance.htm (accessed February 2, 2023).

Terracciano, L., J. Brozek, E. Compalati, and H. Schünemann. 2010. Grade system: New paradigm. Current Opinion in Allergy and Clinical Immunology 10(4):377–383. https://doi.org/10.1097/ACI.0b013e32833c148b.

Vedula, S. S., L. Bero, R. W. Scherer, and K. Dickersin. 2009. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. New England Journal of Medicine 361(20):1963–1971. https://doi.org/10.1056/NEJMsa0906126.

Wieseler, B., M. F. Kerekes, V. Vervoelgyi, N. McGauran, and T. Kaiser. 2012. Impact of document type on reporting quality of clinical drug trials: A comparison of registry reports, clinical study reports, and journal publications. BMJ 344:d8141. https://doi.org/10.1136/bmj.d8141.

Wieseler, B., N. Wolfram, N. McGauran, M. F. Kerekes, V. Vervölgyi, P. Kohlepp, M. Kamphuis, and U. Grouven. 2013. Completeness of reporting of patient-relevant clinical trial outcomes: Comparison of unpublished clinical study reports with publicly available data. PLoS Medicine 10(10):e1001526. https://doi.org/10.1371/journal.pmed.1001526.

This page intentionally left blank.